Opinion · 29 Jun 2025
Short communicationPublished 12 Sep 2020
Obesity correlation with metastases development and response to first-line metastatic chemotherapy in breast cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To compare breast cancer metastases between obese and non-obese women and to evaluate the effect of first-line metastatic chemotherapy in each group A retrospective study was performed in an educational institute in Ireland. The study consisted of two parts: the first part was a comparative analysis of metastases development in obese (arm A) and non-obese patients (arm B). The second part was a comparison between both arms in relation to their response to first-line metastatic chemotherapy and their survival data. Between 2009 and 2014, we reviewed 118 patients with metastatic breast cancer. All the patients fulfilled our inclusion criteria. In all, 48% of patients were obese and 52% were non obese. There were no statistically significant differences between the two groups. For arms A and B, the median interval between initial cancer diagnosis and distant metastases development (distant metastases-free survival) was 5.8 versus 7.6 years, respectively (P value 0.04). Earlier visceral (liver and lung) metastases were observed in obese compared to non-obese women (P values were 0.05 and 0.04, respectively). The most commonly used chemotherapy was weekly paclitaxel. Our treatments showed significantly better treatment response and better survival results in non-obese women than in obese ones, who were premenopausal with performance state 2, pathological grade 3, and four or more positive lymph nodes.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Cancer Clinical Research.
Opinion · 29 Jun 2025
Enhancing Cardiac Diagnosis with T1 Mapping in Cardiac MRI
Mini review · 29 Jun 2025
Understanding Fibroblast Activation in Physiological and Pathological Processes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Mohammed Osman”
